Therapeutic Potential for Cytokine Antagonists: Thalidomide and Pentoxifylline in Hansen’s Disease
Cytokine antagonists are a group of drugs defined by their actions on specific cytokines. Cytokine antagonists can inhibit action of cytokines by acting directly on receptors, by affecting production of cytokines or by binding to cytokines and preventing their subsequent action. Recent evidence sugg...
Main Author: | Theresa C Peterson |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
1995-01-01
|
Series: | Canadian Journal of Infectious Diseases |
Online Access: | http://dx.doi.org/10.1155/1995/503276 |
Similar Items
-
Hypothesis: Pentoxifylline is a potential cytokine modulator therapeutic in COVID‐19 patients
by: Bruce M. Hendry, et al.
Published: (2020-08-01) -
Thalidomide and pentoxifylline block the renal effects of supernatants of macrophages activated with Crotalus durissus cascavella venom
by: A.M.C. Martins, et al.
Published: (2004-10-01) -
Double-blind trial of the efficacy of pentoxifylline vs thalidomide for the treatment of type II reaction in leprosy
by: A.M. Sales, et al.
Published: (2007-02-01) -
Potential therapeutic effects of pentoxifylline against COVID-19
by: Atefeh Abedini, et al.
Published: (2020-01-01) -
Hypnotherapy: A useful adjunctive therapeutic modality in hansen′s disease
by: E N Abdul Latheef, et al.
Published: (2014-01-01)